READ MOREArticles22nd October 2015LCJ InvestmentsThe LCJ FX Macro Strategy is a fundamental and discretionary global macro strategy expressed through currencies.
READ MOREArticles10th February 2014350IP Beats Targets350 Investment Partners (350IP), managers of The North West Fund for Energy and Environmental, has succeeded 2013 portfolio targets, investing in seven new clean tech and green energy companies across the region.
READ MOREArticles4th December 2023Private Placement ProgrammeSamorekand Trade Finance WHY US? We specialize and advise affluent clients and established companies including institutions such as hedge funds, pension funds, and insurance companies to successfully transact and close commodity buy/sell transactions including high-performance investment vehicles and financial instruments such as MTNs, SBLC, and PPP programs. We also provide one of the largest networks […]
READ MOREArticles10th February 2014Confluence Launches in DublinConfluence, the global leader in investment data management automation, has continued its expansion by opening an office in Ireland.
READ MOREArticles2nd May 2014Bulk Annuity Market Should be Priority for InsurersMore insurers should focus on the bulk annuity market if they expect to write fewer individual annuities under the new pensions regime announced in the recent budget, says American global professional services firm Towers Watson.
READ MOREArticles14th April 2015Mobile Learning Market Worth $37.60 Billion by 2020According to a new market research report "Mobile Learning Market by Solution (Mobile Content Authoring, E-books, Portable LMS, Mobile and Video-based Courseware, Interactive Assessments, Content Development, M-Enablement), by Applications, by User Type, & by Region - Global Forecast to 2020", published by MarketsandMarkets, Mobile Learning Market to grow from $7.98 Billion in 2015 to $37.60 Billion by 2020, at a Compound Annual Growth Rate (CAGR) of 36.3%.
READ MOREArticles22nd May 2014Strong Q1 for Life Sciences InvestmentVenture capital funding for the Life Sciences sector, which includes Biotechnology and Medical Devices, increased 15% in value during the first quarter of 2014, compared to first quarter of 2013, according to a new PwC US report.